Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Gilead Sciences GermanyGilead Sciences Germany
VS
BioconBiocon
Gilead Sciences Germany

Gilead Sciences Germany

Fraunhoferstr. 17, Martinsried , 82152, DE

Last Update: 10/03/2026

View Profile
752/1000Fair

Über Gilead Sciences Germany Bei Gilead verfolgen wir seit mehr als 35 Jahren das Unmögliche und wir stecken uns dabei ehrgeizige Ziele. Unsere Mission: die Welt für alle Menschen zu einem gesünderen Ort machen. Deshalb entwickeln und vertreiben wir innovative Arzneimit...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Biocon

Biocon

Hosur Road, Electronics City, Bangalore, Karnataka, IN, 560100

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.biocon.com
773/1000Fair

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:11,558
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Gilead Sciences Germany

Gilead Sciences Germany

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Biocon

Biocon

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gilead Sciences Germany in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biocon in 2026.

Incidents

Incident History - Gilead Sciences Germany (X = Date, Y = Severity)

Gilead Sciences Germany cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Biocon (X = Date, Y = Severity)

Biocon cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Gilead Sciences Germany

Gilead Sciences Germany

Incidents
No explicit notable incidents reported.
Biocon

Biocon

Incidents
No explicit notable incidents reported.

FAQ

Between Gilead Sciences Germany company and Biocon company, which one has the best AI Cybersecurity Score ?
Between Gilead Sciences Germany company and Biocon company, which one has experienced more cyber incidents in the past ?
Between Gilead Sciences Germany company and Biocon company, which one has experienced more cyber incidents this year ?
Between Gilead Sciences Germany company and Biocon company, which one has experienced at least one ransomware attack ?
Between Gilead Sciences Germany company and Biocon company, which one has experienced at least one data breach ?
Between Gilead Sciences Germany company and Biocon company, which one has experienced at least one targeted cyberattack ?
Between Gilead Sciences Germany company and Biocon company, which one has experienced at least one vulnerability ?
Between Gilead Sciences Germany company and Biocon company, which one holds the most compliance certifications ?
Between Gilead Sciences Germany company and Biocon company, which one holds the fewest compliance certifications ?
Between Gilead Sciences Germany company and Biocon company, which one has the most subsidiaries ?
Between Gilead Sciences Germany company and Biocon company, which one has the largest number of employees ?
Between Gilead Sciences Germany and Biocon, which company holds both SOC 2 Type 1 certifications ?
Between Gilead Sciences Germany and Biocon, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Gilead Sciences Germany or Biocon ?
Which company is PCI DSS compliant - Gilead Sciences Germany or Biocon ?
Between Gilead Sciences Germany and Biocon, which company complies with HIPAA regulations for healthcare data ?
Between Gilead Sciences Germany and Biocon, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-103761
SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a memory exhaustion vulnerability in TransferMetadata::receivePeerNotify that allows unauthenticated attackers to grow process memory without limit. Attackers can repeatedly send notify frames up to 1 MB to the handshake RPC port, filling the uncapped notifys vector until the out-of-memory killer terminates the engine.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-103760
SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a denial of service vulnerability that allows unauthenticated remote attackers to block the handshake daemon by never reading replies. Attackers can send a Metadata request to the handshake RPC port and stall SocketHandShakePlugin's single listener thread in writeFully(), breaking all subsequent handshakes, metadata fetches, notify and probe requests.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 5.9)
CVSS3
Base Score: 5.9
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.2
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.2
CVE-2025-71427
SUMMARY

Office-PowerPoint-MCP-Server through 2.0.7 contains a path traversal vulnerability that allows MCP callers to write and read files outside the working directory by supplying absolute paths or ../ sequences. Attackers can steer an AI agent via prompt injection to abuse save_presentation, open_presentation, or manage_image output_path to overwrite any server-writable file or load external files.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-86344
SUMMARY

A flaw was found in 389-ds-base. An unauthenticated remote attacker can send a complete LDAP operation followed by the first bytes of an incomplete LDAPMessage on the same connection, causing the server to hand that connection to a second worker thread before the first worker's result is flushed. The second worker blocks until nsslapd-ioblocktimeout while holding the connection mutex, preventing delivery of the completed operation's result. Repeating this across a small number of connections proportional to the configured worker-thread pool size exhausts the entire pool under default configuration, denying service to all clients (anonymous and authenticated, plaintext and TLS) for as long as the attacker maintains the connections.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-71454
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in CWE-79 - Cross-site Scripting CAPEC-63 allows Cross-Site Scripting (XSS). This issue affects CAPEC-63: before 3.0b63.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA